Cargando…
P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012123/ http://dx.doi.org/10.1097/01.HS9.0000829636.39178.19 |
| _version_ | 1784687736167333888 |
|---|---|
| author | Terpos, E Ntanasis-Stathopoulos, I Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, E Gavriatopoulou, M Leonidakis, A Delimpasi, S Malandrakis, P Kyrtsonis, M-C Papaioannou, M Symeonidis, A Dimopoulos, MA |
| author_facet | Terpos, E Ntanasis-Stathopoulos, I Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, E Gavriatopoulou, M Leonidakis, A Delimpasi, S Malandrakis, P Kyrtsonis, M-C Papaioannou, M Symeonidis, A Dimopoulos, MA |
| author_sort | Terpos, E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9012123 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90121232022-04-18 P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY Terpos, E Ntanasis-Stathopoulos, I Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, E Gavriatopoulou, M Leonidakis, A Delimpasi, S Malandrakis, P Kyrtsonis, M-C Papaioannou, M Symeonidis, A Dimopoulos, MA Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9012123/ http://dx.doi.org/10.1097/01.HS9.0000829636.39178.19 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Poster Terpos, E Ntanasis-Stathopoulos, I Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, E Gavriatopoulou, M Leonidakis, A Delimpasi, S Malandrakis, P Kyrtsonis, M-C Papaioannou, M Symeonidis, A Dimopoulos, MA P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_full | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_fullStr | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_full_unstemmed | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_short | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_sort | p16: daratumumab monotherapy has a favorable effect on bone metabolism in patients with relapsed/refractory multiple myeloma; results of the phase 2 rebuild study |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012123/ http://dx.doi.org/10.1097/01.HS9.0000829636.39178.19 |
| work_keys_str_mv | AT terpose p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT ntanasisstathopoulosi p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT kastritise p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT hatjiharissie p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT katodritoue p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT eleutherakispapaiakovoue p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT verroue p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT gavriatopouloum p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT leonidakisa p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT delimpasis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT malandrakisp p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT kyrtsonismc p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT papaioannoum p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT symeonidisa p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT dimopoulosma p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy |